POM
Insulgen 100IU Injection
Sh 15,000
Prescription Might be required at Checkout
Add a review
Insulgen 100IU Injection
Your review
* Review is required
Name
* Name is required
Email
* Email is required
Add photos or video to your review
| 5 star | 0% | |
| 4 star | 0% | |
| 3 star | 0% | |
| 2 star | 0% | |
| 1 star | 0% |
0 of 0 reviews
Sorry, no reviews match your current selections
Share this Product
More Details on This Product
Insulgen 40 IU Injection
Insulgen 40 IU Injection is a short-acting human insulin designed to manage postprandial blood glucose in patients with diabetes mellitus. It provides rapid glucose-lowering effects, supporting safe and effective glycemic control in adults and children.
Available Models/Sizes/Variations
- Vial size: 1 mL containing 40 IU insulin
- Concentration: 40 IU/mL
Main Intended Uses (with localized benefits)
- Short-term glycemic control for type 1 diabetes
- Supplementary insulin for type 2 diabetes
- Supports safe diabetes management in Tanzanian homes and clinics
Operating Instructions
- Inspect vial; solution should be clear and colorless.
- Administer subcutaneously using sterile syringe or pen before meals.
- Rotate injection sites to prevent lipodystrophy.
- Adjust dose according to blood glucose monitoring and medical advice.
- Discard vial 4 weeks after first use.
Potential Risks / Adverse Events
- Hypoglycemia (low blood sugar)
- Injection site reactions (redness, swelling)
- Weight gain or rare allergic reactions
Interactions / Compatibility
- May interact with oral antidiabetic drugs, corticosteroids, beta-blockers, ACE inhibitors, or other medications affecting blood sugar.
Warnings / Precautions (with localized warnings)
- Store in refrigerator at 2–8°C; do not freeze.
- Do not mix with other insulins unless prescribed by a doctor.
- Monitor blood glucose levels regularly.
- Keep out of reach of children.
Quick Device Facts Table
| Item | Detail |
|---|---|
| Device Type | Short-acting human insulin |
| Intended Use | Postprandial blood sugar control |
| Operating Environment | Home or clinic; subcutaneous injection |
| Sterilization Method | Single-use syringe or pen required |
| Potential Risks | Hypoglycemia, injection site reactions |
| Warnings | Store 2–8°C; discard after 4 weeks |
Mechanism of Operation
Insulgen delivers rapid-acting insulin that lowers post-meal blood glucose by enhancing cellular glucose uptake and suppressing hepatic glucose production.
Pay How Ever You Want
Â
- Pay via Mobile Money, bank, or card.
- Payments are safe and encrypted.
Delivery Across Tanzania
Delivery Across Tanzania
- We deliver to all regions.
- Orders arrive in 2–4 business days.
- Same-day delivery in Dar es Salaam.
- Free delivery for orders above TZS 250,000.
We Are a Real Pharmacy
Â
- Licensed by the Pharmacy Council of Tanzania.
- All products are genuine.
- Registration can be verified online.
Loging / Register for Bulk Purchase
Login or Register to instantly unlock special wholesale price discounts for eligible products.
Diabetics or
Hypetensive?
Introducing JaliCare
- Get Monthly medicine delivery.
- Consumables Discounts.
- Excepts Health Check-ins.
Add a review
Insulgen 100IU Injection
Your review
* Review is required
Name
* Name is required
Email
* Email is required
Add photos or video to your review
Details
Insulgen 40 IU Injection
Insulgen 40 IU Injection is a short-acting human insulin designed to manage postprandial blood glucose in patients with diabetes mellitus. It provides rapid glucose-lowering effects, supporting safe and effective glycemic control in adults and children.
Available Models/Sizes/Variations
- Vial size: 1 mL containing 40 IU insulin
- Concentration: 40 IU/mL
Main Intended Uses (with localized benefits)
- Short-term glycemic control for type 1 diabetes
- Supplementary insulin for type 2 diabetes
- Supports safe diabetes management in Tanzanian homes and clinics
Operating Instructions
- Inspect vial; solution should be clear and colorless.
- Administer subcutaneously using sterile syringe or pen before meals.
- Rotate injection sites to prevent lipodystrophy.
- Adjust dose according to blood glucose monitoring and medical advice.
- Discard vial 4 weeks after first use.
Potential Risks / Adverse Events
- Hypoglycemia (low blood sugar)
- Injection site reactions (redness, swelling)
- Weight gain or rare allergic reactions
Interactions / Compatibility
- May interact with oral antidiabetic drugs, corticosteroids, beta-blockers, ACE inhibitors, or other medications affecting blood sugar.
Warnings / Precautions (with localized warnings)
- Store in refrigerator at 2–8°C; do not freeze.
- Do not mix with other insulins unless prescribed by a doctor.
- Monitor blood glucose levels regularly.
- Keep out of reach of children.
Quick Device Facts Table
| Item | Detail |
|---|---|
| Device Type | Short-acting human insulin |
| Intended Use | Postprandial blood sugar control |
| Operating Environment | Home or clinic; subcutaneous injection |
| Sterilization Method | Single-use syringe or pen required |
| Potential Risks | Hypoglycemia, injection site reactions |
| Warnings | Store 2–8°C; discard after 4 weeks |
Mechanism of Operation
Insulgen delivers rapid-acting insulin that lowers post-meal blood glucose by enhancing cellular glucose uptake and suppressing hepatic glucose production.
Q & A
Ask a question
Insulgen 100IU Injection
Your question
* Question is required
Name
* Name is required
Email
* Email is required
There are no questions yet
Reviews
There are no reviews yet